The effects of regular inhaled formoterol, budesonide, and placebo on mucosal inflammation and clinical indices in mild asthma

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 1, 1999, Pages 79-86

  Wallin, Annika ^a   Sandström, Thomas ^b   Söderberg, Margaretha ^b   Howarth, Peter ^b   Lundbäck, Bo ^b   Della Cioppa, Giovanni ^b   Wilson, Susan ^b   Judd, Mary ^b   Djukanović, Ratko ^b   Holgate, Stephen ^b   Lindberg, Anne ^b   Larssen, Lars ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; FORMOTEROL; FORMOTEROL FUMARATE;

ADULT; ALLERGIC ASTHMA; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRONCHUS BIOPSY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MAST CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032924959     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.1.9801007     Document Type: Article

References (35)

1. Holgate, S. T. 1997. Asthma: a dynamic disease of inflammation and repair. In The Rising Trends in Asthma. CIBA Foundation Symposium No. 206. John Wiley & Sons, Chichester, UK. 5-34.
2. Djukanović, R., J. W. Wilson, K. M. Britten, S. J. Wilson, A. F. Walls, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1990. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am. Rev. Respir. Dis. 142:863-871.
3. Robinson, D., Q. Hamid, A. Bentley, S. Ying, A. B. Kay, and S. R. Durham. 1993. Activation of CD4+ T cells, increased Th-2 type cytokine mRNA expression and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma. J. Allergy Clin. Immunol. 92:313-324.
4. Walsh, G. M. 1997. Mechanisms of human eosinophil survival and apoptosis. Clin. Exp. Allergy 27:482-487.
5. Global Strategy for Asthma Management and Prevention. 1995. NHLBI/WHO Workshop Report. National Institutes of Health, Bethesda, MD. NIH Publication No. 95-3659.
6. National Asthma Education and Prevention Program Expert Panel. 1997. Expert Panel No. 2: Guidelines to the Diagnosis and Management of Asthma. National Heart and Blood Institute, Bethesda, MD. NIH Publication No. 97-4051.
7. 2 agonist, terbutaline, on airway inflammation in newly diagnosed asthma: a randomised double-blind, parallel-group controlled study. J. Allergy Clin. Immunol. 90:32-42.
8. Djukanović, R., A. F. Walls, J. W. Wilson, C. Walters, K. M. Britten, S. Wilson, M. K. Church, P. H. Howarth, and S. T. Holgate. 1991. The effect of inhaled beclomethasone dipropionate (BDP) on airway mast cells, histamine and tryptase in atopic asthma (abstract). Am. Rev. Respir. Dis. 143:A267.
9. Greening, A., P. Wind, M. Northfield, and G. Shaw. 1994. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroids. Lancet 344:219-224.
10. Woolcock, A., B. Lundbäck, O. L. N. Ringdal, and L. A. Jacques. 1994. Comparison of the effect of addition of salmeterol with doubling the inhaled steroid dose in asthmatic patients (abstract). Am. J. Respir. Crit. Care Med. 149:A280.
11. British Asthma Guidelines Co-ordinating Committee. 1997. British guidelines on asthma management: 1995 review and position statement. Thorax 52(Suppl.):S1-24.
12. Arvidsson, P., S. Larsson, C.-G. Löfdahl, B. Melander, L. Wåhlander, and N. Svedmyr. 1989. Formoterol, a new bronchodilator for inhalation. Eur. Respir. J. 2:325-330.
13. Nelson, H. S., S. J. Szefler, and R. J. Martin. 1991. Regular inhaled β-adrenergic agonists in the treatment of bronchial asthma: beneficial or detrimental? Am. Rev. Respir. Dis. 14:249-250.
14. Drazen, J. M., E. Israel, H. A. Boushey, V. M. Chinchilli, J. V. Fahy, J. E. Fish, S. C. Lazarus, R. F. Lemanske, R. J. Martin, S. P. Peters, C. Sorkness, and S. J. Szefler. 1996. Comparison of regularly scheduled with as needed use of albuterol in mild asthma. N. Engl. J. Med. 335:841-847.
15. 20: comparison of linear and logarithmic interpolation. Chest 84:505-506.
16. 2 on the airways of healthy subjects. Am. J. Respir. Crit. Care Med. 156:418-424.
17. National Institutes of Health. 1985. Summary and recommendations of a workshop on the investigative use of fiberoptic bronchscopy and bronchoalveolar lavage in asthmatics. Am. Rev. Respir. Dis. 132:180-182.
18. Britten, K. M., P. H. Howarth, and W. R. Roche. 1993. Immunohistochemistry on resin sections: a comparison of resin embedding techniques for small mucosal biopsies. Biothec. Histochem. 68:271-280.
19. Vathenen, A. S., A. J. Knox, B. G. Higgins, J. R. Britton, and A. E. Tattersfield. 1988. Rebound increase in bronchial responsiveness after treatment with inhaled terbutaline. Lancer 1:554-558.
20. O'Connor, B. J., S. L. Aikman, and P. J. Barnes. 1992. Tolerance to the non-bronchodilalor effects of inhaled beta agonists in asthma. N. Engl. J. Med. 327:1204-1208.
21. Cheung, D., M. C. Timmers, A. H. Zwinderman, E. H. Bel, J. H. Dijman, and P. J. Sterk. 1992. Long term effects of a long acting adrenoceptor agonist, salmeterol, on airway hyperresponsiveness patients with mild asthma. N. Engl. J. Med. 327:1198-1203.
22. Giannini, D., A. Carletti, F. L. Dente, E. Bacci, A. D. Franci, B. Vaggini, and P. L. Paggiaro. 1996. Tolerance to the protective effect of meterol on allergen challenge. Chest 110:1452-1457.
23. Cockcroft, D. W., P. M. O'Byrne, V. A. Swystun, and R. Bhagat. Regular use of inhaled albuterol and the allergen-induced late asthmatic response. J. Allergy Clin. Immunol. 96:44-49.
24. Djukanović, R., C. W. K. Lai, J. W. Wilson, K. M. Britten, S. J. Wilson, W. R. Roche, P. H. Howarth, and S. T. Holgate. 1992. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur. Respir. J. 5:538-544.
25. Wilson, J. W., R. Djukanović, P. H. Howarth, and S. T. Holgate Inhaled beclomethasone dipropionate down regulates airway lymphocyte activation in atopic asthma. Am. J. Respir. Crit. Care Med. 86-90.
26. Twentyman, O. P., J. P. Finnerty, A. Harris, J. Palmer, and S. T. Holgate. 1990. Protection against allergen-induced asthma by salmeterol. Lancet 336:1338-1342.
27. Wong, B., J. Dolovich, E. H. Ramsdale, P. O'Byrne, J. A. Gontovnick, A. Denburg, and F. E. Hargreave. 1992. Formoterol compared with beclomethasone and placebo on allergen-induced asthmatic responses. Am. Rev. Respir. Dis. 146:1156-1160.
28. Bancalari, L., F. L. Dente, A. Carletti, S. Cianchetti, S. Carnevali, M. L. Bartoli, E. Bacci, A. Di Franco, D. Giannini, R. Testi, M. Ferdeghini, and P. L. Paggiaro. 1996. Effect of salmeterol on eosinophil counts in induced sputum after late airway response to allergen inhalation in asthmatic subjects (abstract). Eur. Respir. J. 9(Suppl. 23):136s.
29. Brick, J. J., K. L. Hinton, T. Vuchinich, and W. J. Calhoun. 1996. Effects of salmeterol (sal) on eosinophil recruitment to the airway following segmental antigen challenge (SAC) in atopic asthmatics (abstract). Am. J. Respir. Crit. Care Med. 153:A804.
30. Jeffery, P. K., R. W. Godfrey, E. Ädelroth, F. Nelson, A. Rogers, and S.-A. Johansson. 1992. Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. Am. Rev. Respir. Dis. 145:890-899.
31. Roberts, J. A., P. Bradding, A. F. Walls, S. T. Holgate, and P. H. Howarth. 1992. The effect of salmeterol xinafoate therapy on lavagefindings in asthma (abstract). Am. Rev. Respir. Dis. 145:A418.
32. Gardiner, P. V., C. Ward, H. Boose, S. A. Alison, D. J. Henrick, and D. H. Walter. 1994. Effect of eight weeks of treatment with salmeterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am. J. Respir. Crit. Care Med. 150:1006-1011.
33. Li, D., D. Wang, P. Venge, R. Dahlr, P. Farschou, and P. Jeffrey. 1997. Comparison of the anti-inflammatory effects of inhaled fluticasone propionate and salmeterol in asthma: a placebo controlled cross-over study of bronchial biopsies (abstract). Eur. Respir. J. 10(Suppl. 25):444s.
34. Finnerty, J. P., C. Lee, S. Wilson, J. Madden, R. Djukanović, and S. T. Holgate. 1996. Effects of theophylline on inflammatory cells in asthmatic subjects: a placebo-controlled parallel group study. Eur. Respir. J. 9:1672-1677.
35. Pauwels, R. A., C.-G. Löfdahl, D. S. Postma, A. E. Tattersfield, P. O'Byrne, P. J. Barnes, and A. Ullman. 1997. The effect of inhaled formoterol and budesonide on exacerbations of asthma. N. Engl. J. Med. 337:1405-1411.